Oxcarbazepine in pharma franchise in Himachal Pradesh

Oxcarbazepine in PCD pharma franchise in Imphal

Oxcarbazepine in top pharma company in Gangtok

Oxcarbazepine in pcd pharma supplier in Indore

Oxcarbazepine in phama franchise company in India
Oxcarbazepine in phama distributor in Ranchi

Home/Products /oxcarbazepine-i-point-p-point-300mg-tablet

Oxcelzine 300 Tablet

Composition : Oxcarbazepine I.P. 300mg Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹229/-

Oxcelzine 300 Tablet contains Oxcarbazepine I.P. 300mg, an anticonvulsant medication primarily used to manage epilepsy and prevent seizures. It works by stabilizing electrical activity in the brain, thereby reducing the frequency and severity of seizures. Oxacrip 300 is also beneficial in managing other conditions like partial seizures and is often used as an adjunctive therapy for epilepsy. Its mechanism of action involves blocking sodium channels in the brain, which helps control the electrical impulses that lead to seizures.

Oxcarbazepine, the active ingredient in Oxacrip 300, is known for its efficacy in controlling seizure activity. It is commonly prescribed to patients who have not responded well to other antiepileptic drugs or require additional treatment for seizure management. Oxacrip 300 also plays a role in managing mood disorders like bipolar disorder, where it helps stabilize mood fluctuations. The medication is typically taken in tablet form and is absorbed into the bloodstream, where it begins to take effect in controlling seizure activity.

Patients taking Oxcelzine 300 Tablet may experience significant improvements in seizure control and quality of life, especially when used in conjunction with other antiepileptic medications. As with any anticonvulsant therapy, the dosage should be carefully tailored to each individual, with close monitoring to avoid side effects and interactions with other drugs.

Read More

About the Product

Oxcelzine 300 Tablet contains Oxcarbazepine I.P. 300mg, an anticonvulsant medication primarily used to manage epilepsy and prevent seizures. It works by stabilizing electrical activity in the brain, thereby reducing the frequency and severity of seizures. Oxacrip 300 is also beneficial in managing other conditions like partial seizures and is often used as an adjunctive therapy for epilepsy. Its mechanism of action involves blocking sodium channels in the brain, which helps control the electrical impulses that lead to seizures.

Oxcarbazepine, the active ingredient in Oxacrip 300, is known for its efficacy in controlling seizure activity. It is commonly prescribed to patients who have not responded well to other antiepileptic drugs or require additional treatment for seizure management. Oxacrip 300 also plays a role in managing mood disorders like bipolar disorder, where it helps stabilize mood fluctuations. The medication is typically taken in tablet form and is absorbed into the bloodstream, where it begins to take effect in controlling seizure activity.

Patients taking Oxcelzine 300 Tablet may experience significant improvements in seizure control and quality of life, especially when used in conjunction with other antiepileptic medications. As with any anticonvulsant therapy, the dosage should be carefully tailored to each individual, with close monitoring to avoid side effects and interactions with other drugs.

Common side effects may include dizziness, fatigue, nausea, and headache. More serious side effects include skin reactions, hyponatremia (low sodium), and allergic reactions. Consult a healthcare provider if any severe symptoms arise.

Oxacrip 300 is indicated for the treatment of partial seizures in epilepsy, as well as for use as an adjunct in combination therapy for generalized seizures.

Take Oxacrip 300 as prescribed by your doctor; sudden discontinuation may increase the risk of seizures.

Store in a cool, dry place, away from direct sunlight, and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation